Cargando…
Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation
Major depressive disorder (MDD) is a chronic condition that affects one in six adults in the US during their lifetime. The current practice of antidepressant medication prescription is a trial-and-error process. Additionally, over a third of patients with MDD fail to respond to two or more antidepre...
Autores principales: | Jha, Manish K., Trivedi, Madhukar H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796181/ https://www.ncbi.nlm.nih.gov/pubmed/29329256 http://dx.doi.org/10.3390/ijms19010233 |
Ejemplares similares
-
Platelet-Derived Growth Factor as an Antidepressant Treatment Selection
Biomarker: Higher Levels Selectively Predict Better Outcomes with Bupropion-SSRI
Combination
por: Jha, Manish K, et al.
Publicado: (2017) -
Worsening Anxiety, Irritability, Insomnia, or Panic Predicts Poorer Antidepressant Treatment Outcomes: Clinical Utility and Validation of the Concise Associated Symptom Tracking (CAST) Scale
por: Jha, Manish K, et al.
Publicado: (2017) -
Addressing adherence to antidepressant treatment for depression
por: Mayes, Taryn L., et al.
Publicado: (2020) -
Psychometric Properties of the Concise Associated Symptom Tracking Scale and Validation of Clinical Utility in the EMBARC Study
por: Minhajuddin, Abu, et al.
Publicado: (2020) -
Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder
por: Jha, Manish K, et al.
Publicado: (2017)